Variegate porphyria induces plasma and neutrophil oxidative stress: effects of dietary supplementation with vitamins E and C - PubMed (original) (raw)
Clinical Trial
Variegate porphyria induces plasma and neutrophil oxidative stress: effects of dietary supplementation with vitamins E and C
Miguel D Ferrer et al. Br J Nutr. 2010 Jan.
Abstract
Our aim was to analyse the influence of variegate porphyria (VP) on the antioxidant defenses and markers of oxidative damage and inflammation in plasma and neutrophils and the effects of dietary supplementation with vitamins E and C on these parameters in plasma, neutrophils and erythrocytes. Twelve women affected by VP and twelve pair-matched healthy control women participated in a double-blind crossover study. Each participant took 50 mg/d of vitamin E and 150 mg/d of vitamin C, or a placebo, for 6 months, by consuming an almond-based beverage as the vehicle. Women affected by VP presented higher C-reactive protein and malondialdehyde (MDA) circulating levels. Plasma antioxidant defenses were not different between porphyric and control women. Neutrophils from VP women presented decreased catalase (CAT) and glutathione reductase (GR) activities together with increased protein carbonyl levels. Reactive oxygen species (ROS) production from stimulated neutrophils was also higher in porphyric women than their controls. Dietary supplementation was effective in increasing alpha-tocopherol levels in neutrophils and in reducing MDA levels in plasma. Erythrocyte CAT and GR activities were enhanced by the enriched beverage only in the control subjects. In conclusion, women affected by VP present a situation of inflammation, plasma oxidative damage and neutrophils more primed to the oxidative burst, with decreased antioxidant activities and increased ROS production capabilities and protein oxidative damage. Dietary supplementation with vitamin E (50 mg/d) and vitamin C (150 mg/d) for 6 months decreased plasma oxidative damage and enhanced the erythrocyte activities of CAT and GR.
Similar articles
- Antioxidants restore protoporphyrinogen oxidase in variegate porphyria patients.
Ferrer MD, Tauler P, Sureda A, Palacín C, Tur JA, Pons A. Ferrer MD, et al. Eur J Clin Invest. 2013 Jul;43(7):668-78. doi: 10.1111/eci.12091. Epub 2013 Apr 20. Eur J Clin Invest. 2013. PMID: 23601071 Clinical Trial. - Impaired lymphocyte mitochondrial antioxidant defences in variegate porphyria are accompanied by more inducible reactive oxygen species production and DNA damage.
Ferrer MD, Sureda A, Tauler P, Palacín C, Tur JA, Pons A. Ferrer MD, et al. Br J Haematol. 2010 Jun;149(5):759-67. doi: 10.1111/j.1365-2141.2010.08149.x. Epub 2010 Mar 12. Br J Haematol. 2010. PMID: 20331452 - Vitamins C and E: acute interactive effects on biomarkers of antioxidant defence and oxidative stress.
Choi SW, Benzie IF, Collins AR, Hannigan BM, Strain JJ. Choi SW, et al. Mutat Res. 2004 Jul 13;551(1-2):109-17. doi: 10.1016/j.mrfmmm.2004.03.006. Mutat Res. 2004. PMID: 15225585 Clinical Trial. - Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications.
Rodrigo R, Prieto JC, Castillo R. Rodrigo R, et al. Clin Sci (Lond). 2013 Jan;124(1):1-15. doi: 10.1042/CS20110663. Clin Sci (Lond). 2013. PMID: 22963444 Review. - Vitamin C and lifespan in model organisms.
Pallauf K, Bendall JK, Scheiermann C, Watschinger K, Hoffmann J, Roeder T, Rimbach G. Pallauf K, et al. Food Chem Toxicol. 2013 Aug;58:255-63. doi: 10.1016/j.fct.2013.04.046. Epub 2013 May 1. Food Chem Toxicol. 2013. PMID: 23643700 Review.
Cited by
- Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients.
Ferrer MD, Mestre-Alfaro A, Martínez-Tomé M, Carrera-Quintanar L, Capó X, Jiménez-Monreal AM, García-Diz L, Roche E, Murcia MA, Tur JA, Pons A. Ferrer MD, et al. PLoS One. 2016 Oct 27;11(10):e0164857. doi: 10.1371/journal.pone.0164857. eCollection 2016. PLoS One. 2016. PMID: 27788171 Free PMC article. - Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients.
Martinez MDC, Cerbino GN, Granata BX, Batlle A, Parera VE, Rossetti MV. Martinez MDC, et al. Mol Genet Genomic Med. 2021 May;9(5):e1059. doi: 10.1002/mgg3.1059. Epub 2021 Mar 25. Mol Genet Genomic Med. 2021. PMID: 33764674 Free PMC article. - Protective action of antioxidants on hepatic damage induced by griseofulvin.
Martinez Mdel C, Afonso SG, Buzaleh AM, Batlle A. Martinez Mdel C, et al. ScientificWorldJournal. 2014 Jan 12;2014:982358. doi: 10.1155/2014/982358. eCollection 2014. ScientificWorldJournal. 2014. PMID: 24523661 Free PMC article. - Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy.
Majeed CN, Ma CD, Xiao T, Rudnick S, Bonkovsky HL. Majeed CN, et al. Drug Des Devel Ther. 2022 Jun 16;16:1827-1845. doi: 10.2147/DDDT.S281631. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35734365 Free PMC article. Review. - Nutrients and Porphyria: An Intriguing Crosstalk.
Di Pierro E, Granata F. Di Pierro E, et al. Int J Mol Sci. 2020 May 14;21(10):3462. doi: 10.3390/ijms21103462. Int J Mol Sci. 2020. PMID: 32422947 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous